Wird geladen...
Nanomedicine for the Treatment of Acute Respiratory Distress Syndrome. The 2016 ATS Bear Cage Award–winning Proposal
After dozens of clinical trials, there are still no Food and Drug Administration–approved drugs that improve mortality in acute respiratory distress syndrome (ARDS). These poor results may be caused in part by three unique pharmacological challenges presented by ARDS: (1) Patients with ARDS are frag...
Gespeichert in:
| Veröffentlicht in: | Ann Am Thorac Soc |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Thoracic Society
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5427718/ https://ncbi.nlm.nih.gov/pubmed/28304180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201701-090PS |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|